Biology Reference
In-Depth Information
Erythropoietin in the treatment of iron deficiency anemia during pregnancy.
Gynecol Obstet
Invest
51: 150-156
115 Eckardt KU (2001) After 15 years of success - perspectives of erythropoietin therapy.
Nephrol
Dial Transplant
16: 1745-1749
116 Oster W, Herrmann F, Gamm H, Zeile G, Lindemann A, Muller G, Brune T, Kraemer HP,
Mertelsmann R (1990) Erythropoietin for the treatment of anemia of malignancy associated with
neoplastic bone marrow infiltration.
J Clin Oncol
8: 956-962
117 Abels R (1993) Erythropoietin for anaemia in cancer patients.
Eur J Cancer
29A: S2-S8
118 Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, Schwartz D, Yachnin T,
Steinbruch S, Shapira I et al. (2001) The effect of correction of mild anemia in severe, resistant
congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized
controlled study.
J Am Coll Cardiol
37: 1775-1780
119 Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S,
Schwartz D, Yachnin T et al. (2000) The use of subcutaneous erythropoietin and intravenous iron
for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and
renal function and functional cardiac class, and markedly reduces hospitalizations.
J Am Coll
Cardiol
35: 1737-1744
120 Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Melot C, Vincent JL (1997) Erythropoietin
response is blunted in critically ill patients.
Intensive Care Med
23: 159-162
121 Corwin HL (2001) Anemia in the critically ill:The role of erythropoietin.
Semin Hematol
38:
24-32
122 Olivieri NF (1995) Erythropoietin therapy in inherited anemias (thalassemia and sickle cell dis-
ease).
Int J Ped Hematol/Oncol
2:105-116
123 al Khatti A, Umemura T, Clow J, Abels RI, Vance J, Papayannopoulou T, Stamatoyannopoulos G
(1988) Erythropoietin stimulates F-reticulocyte formation in sickle cell anemia.
Trans Assoc Am
Physicians
101: 54-61
124 Rachmilewitz EA, Goldfarb A, Dover G (1991) Administration of erythropoietin to patients with
beta-thalassemia intermedia: A preliminary trial.
Blood
78: 1145-1147
125 Rund D, Rachmilewitz E (2000) New trends in the treatment of beta-thalassemia.
Crit Rev Oncol
Hematol
33: 105-118
126 Shaskey DJ, Green GA (2000) Sports haematology.
Sports Med
29: 27-38
127 Paul RE, Doerig C, Brey PT (2000) Erythropoiesis and molecular mechanisms for sexual deter-
mination in malaria parasites.
IBUMB Life
49: 245-248
128 Fischl M, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P, Miles S, Robbins W,
Starrett B, Zalusky R (1990) Recombinant human erythropoietin for patients with AIDS treated
with zidovudine.
N Engl J Med
322: 1488-1493
129 Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fischl MA, Gabin SJ,
Gottlieb MS (1992) Recombinant human erythropoietin in the treatment of anemia associated
with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four
clinical trials.
Ann Intern Med
117: 739-748
130 Sheiban E, Gershon H (1993) Recognition and sequestration of young and old erythrocytes from
young and elderly human donors:
In vitro
studies.
J Lab Clin Med
121: 493-501
131 Carbonell-Estrany X, Figueras-Aloy J (2001) Anaemia of prematurity: Treatment with erythro-
poietin.
Early Hum Dev
65: S63-S67
132 Cerami A, Brines M, Ghezzi P, Cerami C, Itri LM (2002) Neuroprotective properties of epoetin
alfa.
Nephrol Dial Transplant
17 Suppl 1: 8-12
133 Wolcott DL, Marsh JT, La Rue A, Carr C, Nissenson AR (1989) Recombinant human erythro-
poietin treatment may improve quality of life and cognitive function in chronic hemodialysis
patients.
Am J Kidney Dis
14: 478-485
134 Nissenson AR (1992) Epoetin and cognitive function.
Am J Kidney Dis
20: 21-24
135 Vaziri ND (2000) Vascular effects of erythropoietin and anemia correction.
Semin Nephrol
20:
356-363
136 Laupacis A, Fergusson D (1998) Erythropoietin to minimize perioperative blood transfusion: A
systematic review of randomized trials. The International Study of Peri-operative Transfusion
(ISPOT) Investigators.
Transfus Med
8: 309-317
137 Goodnough LT, S kikne B, Brugnara C (2000) Erythropoietin, iron, and erythropoiesis.
Blood
96:
823-833
138 Birgegard G, Sandhagen B (2001) Erythropoetin treatment can increase 2,3-diphosphoglycerate
